SYNEOS HEALTH INC (SYNH)
US87166B1026 - Common Stock
SYNEOS HEALTH INC
NASDAQ:SYNH (9/27/2023, 7:00:01 PM)
After market: 42.97 -0.01 (-0.02%)42.98
+0.01 (+0.02%)
Company Profile
Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. The company is headquartered in Morrisville, North Carolina and currently employs 28,768 full-time employees. The company went IPO on 2014-11-07. The firm operates through two business segments: Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. The Clinical Solutions segment offers individual services including product development, project management, protocol development, investigational site recruitment, and clinical monitoring. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions (public relations, advertising, and medical communications), and consulting services. The Company’s customers include small, mid-sized, and large companies in the biopharmaceutical, biotechnology, and medical device industries.
Company Info
SYNEOS HEALTH INC
1030 Sync Street
Morrisville NORTH CAROLINA 27560
P: 19198769300.0
CEO: Alistair Macdonald
Employees: 28768
Website: https://www.syneoshealth.com/
SYNH News
8 months ago - Syneos Health, Inc.Syneos Health Closes Transaction with Private Investment FirmsTransaction Will Drive Ongoing Transformation and Accelerate Delivery of Tech-Enabled, Fit-for-Purpose Solutions to Biopharma Customers
Transaction Will Drive Ongoing Transformation and Accelerate Delivery of Tech-Enabled, Fit-for-Purpose Solutions to Biopharma Customers...
8 months ago - Syneos Health, Inc.Syneos Health Names Terttu Haring President, Clinical Sites & PatientsIndustry Veteran to Play Critical Role in Leading Global Clinical Operations, Cultivating Site Relationships, Empowering Patients and Shaping Innovative Clinical Trial Solutions
8 months ago - TheNewswire.comSYNH DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Syneos Health, Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action - SYNHWHY: NEW YORK, NY - (NewMediaWire) - September 24, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Syneos Health, Inc. (NASDAQ: SYNH) between September 9, 2020 and November 3, 2022, both dates inclusive (the “Class Period”), of the important September 25, 2023 lead plaintiff deadline.
8 months ago - NewMediaWireSYNH DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Syneos Health, Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action - SYNHSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
8 months ago - TheNewswire.comSYNH FINAL DEADLINE MONDAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Syneos Health, Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action - SYNHWHY: NEW YORK, NY - (NewMediaWire) - September 23, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Syneos Health, Inc. (NASDAQ: SYNH) between September 9, 2020 and November 3, 2022, both dates inclusive (the “Class Period”), of the important September 25, 2023 lead plaintiff deadline.
SYNH Twits
Here you can normally see the latest stock twits on SYNH, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
